首頁 > 市場調查報告書 > 醫療設備

導管

市場調查報告書

商品編碼

1741153

纖維蛋白溶解療法市場按藥物類型、適應症、最終用戶、給藥方式、分銷管道、患者年齡、包裝類型、應用、劑型和地區分類

Fibrinolytic Therapy Market By Drug Type, By Indication, By End User, By Administration, By Distribution Channel, By Patient Age, By Packaging Type, By Application, By Dosage Form, By Region

出版日期: 2025年03月26日 | 出版商:

Coherent Market Insights | 英文 260 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計 2025 年纖維蛋白溶解市場規模為 375.9 億美元，到 2032 年將達到 484.8 億美元，2025 年至 2032 年的年複合成長率為 3.7%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	375.9億美元
效能數據	從2020年到2024年	預測期	2025年至2032年
預測期：2025-2032年年複合成長率：	3.70%	2032年價值預測	484.8億美元

纖溶療法用於溶解導致心臟病發作和中風的血栓。雖然它是一種挽救生命的治療方法，但如果存在潛在健康問題，則可能會失敗，並導致其他嚴重和病症。血栓溶解療法通常透過靜脈注射給藥。當患者出現中風或心臟病發作的症狀，且對抗凝血劑和類固醇藥物等其他治療無效時，可以使用該療法。此療法可以在家中或醫院進行。組織纖維蛋白溶酶原活化劑或Alteplase是一種能夠分解纖維蛋白和其他構成體內血栓的物質的藥物，最常用於血栓溶解療法。Tenecteplase對部分患者也有效，可以口服。

市場動態

創傷和道路交通事故的增加推動了對抗纖溶藥物的需求，從而促進了纖溶治療市場的成長。口服止血藥物（主要用於治療月經出血，月經量大）的使用日益增多，預計將進一步推動市場成長。此外，嚴重道路交通事故和創傷性損傷的發生率不斷上升，也帶來了對抗纖溶藥物的需求，推動了市場的成長。此外，這些藥物在血友病和血小板功能障礙、血管性血友病、A型血友病和乙型血友病等其他疾病的治療中得到越來越多的應用，也進一步推動了市場的成長。

全球纖溶療法市場也受到心血管、神經系統和肺部疾病的盛行率上升所推動，這些疾病會導致血栓形成。根據世界衛生組織 (WHO) 的數據，心血管疾病每年導致超過 1,790 萬人死亡。此外，老年人口的成長也促進了市場的成長，老年人更容易患上此類疾病。然而，纖溶藥物的高昂價格、嚴格的監管以及治療相關的出血風險阻礙了市場的擴張。該市場為開發具有更高特異性、增強纖維蛋白特異性並降低出血風險的有效重組、合成類似物和混合分子提供了機會。

然而，這些藥物的高價格是阻礙市場成長的關鍵因素。

本研究的主要特點

本報告對全球纖維蛋白溶解市場進行了詳細分析，並以 2024 年為基準年，展示了預測期 2025-2032 的市場規模和年複合成長率。
它還強調了各個領域的潛在商機，並說明了該市場的有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
它根據公司亮點、產品系列、關鍵亮點、績效和策略等參數，介紹了全球纖維蛋白溶解市場的主要企業概況。
本報告的見解可以幫助負責人和公司經營團隊就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球纖維蛋白溶解市場報告迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員將透過用於分析全球纖維蛋白溶解市場的各種策略矩陣更輕鬆地做出決策。

市場動態
- 促進要素
心血管疾病發生率上升
人口老化加劇
技術進步
獲得醫療保健設施
- 限制因素
在某些患者族群中療效有限
出血併發症的風險
替代治療方法的可用性
時間敏感性和入院到入針延遲
- 機會
新興市場
聯合治療
遠端醫療和遠端醫療
個人化醫療
- 主要亮點
- 監管情景
- 近期動態
- 產品發布/核准
- PEST分析
- 波特分析
- 合併、收購和合作

4. 全球纖維蛋白溶解市場-冠狀病毒（COVID-19）大流行的影響

COVID-19流行病學
供需側分析
經濟影響

5. 全球纖溶療法市場（以藥物類型），2020 年至 2032 年

Alteplase
萊泰普拉茲
替奈普利
鏈球菌激酶
安妮斯特普拉斯
尿激酶

6. 全球纖溶療法市場（依適應症分類），2020 年至 2032 年

急性缺血性腦中風
急性心肌梗塞
深層靜脈栓塞症
周邊動脈血栓症
其他動脈血栓症

7. 全球纖維蛋白溶解市場（以最終用戶分類），2020 年至 2032 年

醫院
門診手術中心
專科診所
其他

8. 全球纖維蛋白溶解市場（依管理部門分類），2020 年至 2032 年

靜脈注射（IV）
動脈內（IA）

9. 全球纖維蛋白溶解市場（依通路分類），2020 年至 2032 年

醫院藥房
零售藥局
網路藥局

第 10 章。 2020 年至 2032 年按患者年齡分類的全球纖維蛋白溶解市場

成年患者
兒科患者

第 11 章。 2020 年至 2032 年按包裝類型分類的全球纖維蛋白溶解市場

管瓶
安瓿
預填充式注射器

第 12 章。 2020 年至 2032 年全球纖維蛋白溶解市場（依應用）

緊急醫療
介入性心臟病學
血栓症治療
其他

第 13 章。 2020 年至 2032 年按劑型分類的全球纖溶療法市場

用於復溶的凍乾粉
注射液

第 14 章。 2020 年至 2032 年按地區分類的全球纖維蛋白溶解市場

北美洲
歐洲
亞太地區
拉丁美洲
中東
非洲

第15章競爭格局

公司簡介
- Genentech, Inc.（Roche）
- Bayer AG
- Boehringer Ingelheim International GmbH
- Pfizer Inc.
- Bristol Myers Squibb Company
- Novarts AG
- AstraZeneca PLC
- Johnson &Johnson
- Daiichi Sankyo Company, Limited
- Merck &Co., Inc.
- Sanofi SA
- Takeda Pharmaceutical Company Limited
- Abbott Laboratories
- Mallinckrodt Pharmaceuticals
- Mitsubishi Tanabe Pharma Corporation

第 16 章章節

參考
調查方法
關於出版商

簡介目錄

Product Code: CMI5879

Fibrinolytic Therapy Market is estimated to be valued at USD 37.59 Bn in 2025 and is expected to reach USD 48.48 Bn by 2032, growing at a compound annual growth rate (CAGR) of 3.7% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 37.59 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	3.70%	2032 Value Projection:	USD 48.48 Bn

Fibrinolytic therapy is used to dissolve blood clots that cause heart attacks or strokes. It is a lifesaving treatment, but it fails in underlying health problems that can lead to other serious diseases and conditions. Thrombolysis is usually given through an intravenous line. It is used when symptoms of a stroke or heart attack are present and the patient is not responding to other treatments, like anticoagulants and steroid medications. It can be given at home or in a hospital. Tissue plasminogen activator or alteplase is a drug that breaks down fibrin and other substances that create clots in the body that is most commonly used for thrombolysis. The drug tenecteplase is also effective in some patients, and it can also be given by mouth.

Market Dynamic:

The increasing incidences of trauma and road accidents are driving the demand for antifibrinolytic drugs, which in turn is fuelling fibrinolytic therapy market growth. The growing use of these drugs in oral bleeding treatments, mainly for menorrhagia (heavy menstrual flow) is again anticipated to bolster the market growth further. Moreover, rising incidences of severe road accidents and trauma is creating demand for anti-fibrinolytic drugs, thereby propelling the market growth. Furthermore, rising adoption of these drugs for treating hemophilia and other conditions such as platelet dysfunctions, Von Willebrand diseases and haemophilia A and B is further bolstering the market growth.

Also, the global fibrinolytic therapy market is driven by the rising prevalence of cardiovascular diseases, neurological disorders and pulmonary diseases causing blood clots. As per World Health Organization (WHO), cardiovascular diseases accounts for over 17.9 Mn deaths annually. Moreover, growing geriatric population prone to such diseases contributes to the market growth. However, high costs of fibrinolytic drugs, stringent regulations, and risk of bleeding associated with the therapy inhibits the market expansion. The market provides opportunities for development of effective recombinant variants, synthetic analogs, and hybrid molecules with greater specificity, enhanced fibrin specificity and reduced bleeding risks.

However, the high price of these drugs is a key factor that can hinder the market growth.

Key features of the study:

This report provides in-depth analysis of the global fibrinolytic therapy market, and provides market size (US$ Bn ) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global fibrinolytic therapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Genentech, Inc. (Roche), Bayer AG, Boehringer Ingelheim International GmbH, Pfizer Inc., Bristol Myers Squibb Company, Novartis AG, AstraZeneca PLC, Johnson & Johnson, Daiichi Sankyo Company, Limited, Merck & Co., Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, Abbott Laboratories, Mallinckrodt Pharmaceuticals, and Mitsubishi Tanabe Pharma Corporation
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global fibrinolytic therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global fibrinolytic therapy market

Detailed Segmentation:

Global Fibrinolytic Therapy Market, By Drug Type:
- Alteplase
- Reteplase
- Tenecteplase
- Streptokinase
- Anistreplase
- Urokinase
Global Fibrinolytic Therapy Market, By Indication:
- Acute Ischemic Stroke
- Acute Myocardial Infarction
- Deep Vein Thrombosis
- Peripheral Arterial Thrombosis
- Other Arterial Thrombosis
Global Fibrinolytic Therapy Market, By End User:
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Others
Global Fibrinolytic Therapy Market, By Administration:
- Intravenous (IV)
- Intra-arterial (IA)
Global Fibrinolytic Therapy Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Fibrinolytic Therapy Market, By Patient Age:
- Adult Patients
- Pediatric Patients
Global Fibrinolytic Therapy Market, By Packaging Type:
- Vials
- Ampoules
- Pre-filled Syringes
Global Fibrinolytic Therapy Market, By Application:
- Emergency Care
- Interventional Cardiology
- Thrombosis Treatment
- Others
Global Fibrinolytic Therapy Market, By Dosage Form:
- Lyophilized Powder for Reconstitution
- Solution for Injection
Global Fibrinolytic Therapy Market, By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles
- Genentech, Inc. (Roche)
- Bayer AG
- Boehringer Ingelheim International GmbH
- Pfizer Inc.
- Bristol Myers Squibb Company
- Novartis AG
- AstraZeneca PLC
- Johnson & Johnson
- Daiichi Sankyo Company, Limited
- Merck & Co., Inc.
- Sanofi S.A.
- Takeda Pharmaceutical Company Limited
- Abbott Laboratories
- Mallinckrodt Pharmaceuticals
- Mitsubishi Tanabe Pharma Corporation

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Drug Type
- Market Snippet, By Indication
- Market Snippet, By End User
- Market Snippet, By Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Patient Age
- Market Snippet, By Packaging Type
- Market Snippet, By Application
- Market Snippet, By Dosage Form
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Driver
Increasing incidence of cardiovascular diseases
Growing geriatric population
Technological advancements
Access to healthcare facilities
- Restrain
Limited efficacy in certain patient populations
Risk of bleeding complications
Availability of alternative treatment modalities
Time sensitivity and door-to-needle delays
- Opportunities
Emerging markets
Combination therapies
Telemedicine and remote treatment
Personalized medicine
- Key Highlights
- Regulatory Scenario
- Recent Trends
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Mergers, Acquisitions, and Collaborations

4. Global Fibrinolytic Therapy Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Fibrinolytic Therapy Market, By Drug Type, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2020 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Alteplase
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Reteplase
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Tenacteplase
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Streptokinase
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Anistreplase
- Introduction
- Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Urokinase
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Fibrinolytic Therapy Market, By Indication, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2020 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Acute Ischemic Stroke
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Acute Myocardial Infarction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Deep Vein Thrombosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Peripheral Arterial Thrombosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Other Arterial Thrombosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,US$ Bn(US$ Bn)

7. Global Fibrinolytic Therapy Market, By End User, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2020 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Speciality Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Global Fibrinolytic Therapy Market, By Administration, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2020 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Intravenous (IV)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Intra-arterial (IA)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

9. Global Fibrinolytic Therapy Market, By Distribution Channel, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2020 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

10. Global Fibrinolytic Therapy Market, By Patient Age, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2020 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Adult Patients
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Pediatric Patients
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

11. Global Fibrinolytic Therapy Market, By Packaging Types, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2020 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Vials
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Ampoules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Pre-filled Syringes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

12. Global Fibrinolytic Therapy Market, By Application, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2020 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Emergency Care
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Interventional Cardiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Thrombosis Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

13. Global Fibrinolytic Therapy Market, By Dosage Form, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2020 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Lyophilized Powder for Reconstitution
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Solution for Injection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

14. Global Fibrinolytic Therapy Market, By Region, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2020 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021 -2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Administration, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Administration, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Administration, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Administration, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Administration, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Administration, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Bn)
  - South Africa
  - Central Africa
  - North Africa